LCMT2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.29563026973756E-13 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.16930021221151E-10 |
Normal-vs-Stage2 |
6.24149998351697E-09 |
Normal-vs-Stage3 |
<1E-12 |
Normal-vs-Stage4 |
1.64546154479694E-12 |
Stage1-vs-Stage2 |
2.577600E-01 |
Stage1-vs-Stage3 |
4.66449999958485E-07 |
Stage1-vs-Stage4 |
7.158500E-04 |
Stage2-vs-Stage3 |
8.679500E-02 |
Stage2-vs-Stage4 |
1.471380E-01 |
Stage3-vs-Stage4 |
9.482600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
7.14983627858601E-14 |
Normal-vs-AfricanAmerican |
3.7328999891173E-09 |
Normal-vs-Asian |
2.800000E-02 |
Caucasian-vs-AfricanAmerican |
4.481800E-01 |
Caucasian-vs-Asian |
3.999800E-01 |
AfricanAmerican-vs-Asian |
6.228600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
5.55111512312578E-15 |
Normal-vs-Female |
2.08050021655026E-10 |
Male-vs-Female |
5.040300E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.17369999999661E-07 |
Normal-vs-Age(41-60Yrs) |
1.09356967925578E-13 |
Normal-vs-Age(61-80Yrs) |
3.64819285891826E-13 |
Normal-vs-Age(81-100Yrs) |
7.394700E-04 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.864800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.510800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.195600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.539800E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.069400E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.806200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.484140E-02 |
Normal-vs-Grade 2 |
1.87060034129161E-10 |
Normal-vs-Grade 3 |
1.62447832963153E-12 |
Normal-vs-Grade 4 |
1.62447832963153E-12 |
Grade 1-vs-Grade 2 |
3.669400E-01 |
Grade 1-vs-Grade 3 |
6.715800E-02 |
Grade 1-vs-Grade 4 |
1.184550E-04 |
Grade 2-vs-Grade 3 |
1.521640E-03 |
Grade 2-vs-Grade 4 |
7.6287998140856E-10 |
Grade 3-vs-Grade 4 |
2.814000E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.45839995635555E-09 |
Normal-vs-ccB subtype |
3.33066907387547E-16 |
ccA subtype-vs-ccB subtype |
1.02669999946237E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.62436730732907E-12 |
Normal-vs-N1 |
5.50820000722041E-09 |
N0-vs-N1 |
1.207640E-01 |
|
|